Core Insights - FAVO Capital Inc. has appointed Dr. Wael Barsoum as an independent director to strengthen governance and support its growth strategy [1][3][4] Company Overview - FAVO Capital operates in two core segments: financial services and real estate, providing alternative funding solutions to small and mid-sized businesses across the U.S. [5] - The company has supported over 10,000 businesses through the purchase of future receipts and is building a portfolio of selective real assets to enhance its balance sheet [5] Leadership and Governance - Dr. Wael Barsoum is a recognized healthcare executive with a history of leading complex organizations, including his role as former president and CEO of Cleveland Clinic Florida [2][3] - His appointment is part of FAVO's commitment to building a board with independence and depth to guide the company towards long-term value creation [3][4] - Barsoum has extensive experience in governance, compliance, and organizational transformation, having served on various boards and advisory committees [3]

Independent director adds governance and capital markets expertise as FAVO prepares for long-term growthFORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN – FAVO Capital, Inc. (OTC: FAVO), a diversified financial company operating across two core segments — financial services and real estate — today announced the appointment of Zachary Graeve to its board of directors as an independent director. Graeve will also serve as chair of the Nominating and Corporate Governance Committee. “Zachary’s a ...